Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/NE/Omaha
Updated September 2026 from ClinicalTrials.gov

Paid Clinical Trials in Omaha, NE

Studies commonly pay $75 to $4,500 per completed study

593 clinical trials are currently recruiting participants within 30 miles of Omaha. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

593studies recruiting
9+research centers nearby
5condition categories
Live from the NIH registry

Studies recruiting near Omaha right now

Top 25 of 593 recruiting studies, sorted by proximity — each links to its official registry page

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Lymphoma, Non-Hodgkin, Multiple Myeloma Phase 2 Interventional 4,200 participants sought
University of Nebraska Medical Center — Omaha, Nebraska (5.9 mi) · Sponsor: American Society of Clinical Oncology
See eligibility & contact on ClinicalTrials.gov (NCT02693535)

KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)

Carcinoma, Non-Small-Cell Lung Phase 1, Phase 2 Interventional 450 participants sought
Oncology Hematology West, PC DBA Nebraska Cancer Specialists ( Site 0031) — Omaha, Nebraska (5.9 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT04165070)

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma Phase 2 Interventional 81 participants sought
Nebraska Methodist Hospital — Omaha, Nebraska (5.9 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05112601)

Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD

Age-Related Macular Degeneration, Geographic Atrophy N/A Interventional 125 participants sought
Vance Thompson Vision — Omaha, Nebraska (5.9 mi) · Sponsor: VisionCare, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT05438732)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

B Acute Lymphoblastic Leukemia Phase 2 Interventional 222 participants sought
Children's Hospital and Medical Center of Omaha — Omaha, Nebraska (5.9 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06124157)

A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib

Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma Phase 4 Interventional 787 participants sought
University Of Nebraska Medical Center — Omaha, Nebraska (5.9 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT06876649)

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

Lymphoma, Large B-Cell, Diffuse Phase 2 Interventional 594 participants sought
University Of Nebraska Medical Center ( Site 0110) — Omaha, Nebraska (5.9 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06890884)

GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes

Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus N/A Interventional 400 participants sought
University of Nebraska Medical Center — Omaha, Nebraska (5.9 mi) · Sponsor: Medtronic MiniMed, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07228117)

A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma

Multiple Myeloma, Relapsed/Refractory Multiple Myeloma Phase 2 Interventional 100 participants sought
University of Nebraska Medical Center — Omaha, Nebraska (5.9 mi) · Sponsor: C4 Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07284758)

A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Maribavir for the Treatment of Cytomegalovirus (CMV) Infection in Children and Adolescents Who Have Received a Hematopoietic Stem Cell Transplant (HSCT) or a Solid Organ Transplant (SOT)

Cytomegalovirus (CMV) Phase 3 Interventional 80 participants sought
University of Nebraska Medical Center -985400 Nebraska Medical Center — Omaha, Nebraska (5.9 mi) · Sponsor: Takeda
See eligibility & contact on ClinicalTrials.gov (NCT05319353)

Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer

Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8 Phase 3 Interventional 428 participants sought
Nebraska Medicine-Village Pointe — Omaha, Nebraska (5.9 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05646316)

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)

Heart Failure Phase 3 Interventional 1,500 participants sought
CON-10018, Omaha, NE — Omaha, Nebraska (5.9 mi) · Sponsor: Colorado Prevention Center
See eligibility & contact on ClinicalTrials.gov (NCT06024746)

Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen

Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen Phase 3 Interventional 136 participants sought
Nebraska Methodist Hospital — Omaha, Nebraska (5.9 mi) · Sponsor: Servier Bio-Innovation LLC
See eligibility & contact on ClinicalTrials.gov (NCT06127407)

Minimizing ICU Neurological Dysfunction With Dexmedetomidine-induced Sleep (MINDDS II)

Delirium Phase 3 Interventional 1,800 participants sought
University of Nebraska Medical Center — Omaha, Nebraska (5.9 mi) · Sponsor: Massachusetts General Hospital
See eligibility & contact on ClinicalTrials.gov (NCT06192615)

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma Phase 2 Interventional 40 participants sought
Ohio State University-Telemedicine — Omaha, Nebraska (5.9 mi) · Sponsor: Sameek Roychowdhury
See eligibility & contact on ClinicalTrials.gov (NCT06906562)

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

Percutaneous Coronary Intervention, Peripheral Endovascular Intervention Phase 4 Interventional 6,000 participants sought
Methodist Physicians Clinic Heart Consultants — Omaha, Nebraska (5.9 mi) · Sponsor: Duke University
See eligibility & contact on ClinicalTrials.gov (NCT06909565)

The Short-term Verbal Memory Endophenotype for Developmental Language Disorder Language Disorder

Developmental Language Disorder, Healthy Subjects N/A Interventional 120 participants sought
Boys Town National Research Hospital — Omaha, Nebraska (5.9 mi) · Sponsor: Father Flanagan's Boys' Home
See eligibility & contact on ClinicalTrials.gov (NCT06968169)

A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies

Solid Tumors Phase 2 Interventional 170 participants sought
Local Institution - 0036 — Omaha, Nebraska (5.9 mi) · Sponsor: Mirati Therapeutics Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07415031)

S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer

Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive N/A Interventional 739 participants sought
Alegent Health Immanuel Medical Center — Omaha, Nebraska (5.9 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03723928)

Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections

Pulmonary Invasive Fungal Infections, Pulmonary Invasive Aspergillosis N/A Observational 400 participants sought
Children's Omaha — Omaha, Nebraska (5.9 mi) · Sponsor: Arkansas Children's Hospital Research Institute
See eligibility & contact on ClinicalTrials.gov (NCT03827694)

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma Phase 1 Interventional 694 participants sought
Nebraska Cancer Specialists - Omaha - Wright Street /ID# 247399 — Omaha, Nebraska (5.9 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT05005403)

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

Non-Small Cell Lung Cancer Phase 3 Interventional 675 participants sought
Research Site — Omaha, Nebraska (5.9 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06357533)

A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)

Renal Cell Carcinoma Phase 3 Interventional 904 participants sought
Oncology Hematology West P.C. dba Nebraska Cancer Specialists ( Site 0131) — Omaha, Nebraska (5.9 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT07227402)

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
Nebraska Cancer Specialists/Oncology Hematology West PC - MECC — Omaha, Nebraska (5.9 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03851445)

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

Smoldering Plasma Cell Myeloma Phase 3 Interventional 288 participants sought
Nebraska Medicine-Village Pointe — Omaha, Nebraska (5.9 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT03937635)
Actively enrolling

Studies you may be able to join near Omaha

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for severe chronic itching

Enrolling adults aged 18 to 90 who have had chronic itching for six months or longer. Not open to itching caused by atopic dermatitis, psoriasis, chronic kidney disease, notalgia paresthetica or medication, nor to people with an autoimmune condition such as lupus, Crohn's disease, ulcerative colitis or rheumatoid arthritis.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for heart failure

This study is enrolling adults in eligible areas of the United States who have been diagnosed with heart failure. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Omaha

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Celerion

★ 3.7
8910 Indian Hills Dr #100, Omaha, NE 68114
(866) 563-8844
"Professionals at their best they will here your ear. And take care of every Detail to make u . Feel safe and in good hands love them"
— Rey Gaza, 5★

Quality Clinical Research Inc

★ 4.8
10040 Regency Cir, Omaha, NE 68114
(402) 934-0044
"I’ve always had excellent experiences with QCR. The clinic is very clean and professìonal.The workers are friendly and knowledgeable. I look forward …"
— Marilyn Kirchhoff, 5★

Velocity Clinical Research

★ 4.3
3319 N 107th St, Omaha, NE 68134
(402) 933-6500
"All are happy to answer any questions you have. The front desk lady Sandy is always ready to go above and beyond for clients. Very professional all I…"
— Agnes Jayne, 5★

Durham Research Center

★ 5.0
550 Durham Research Plz, Omaha, NE 68106
"The Durham Research Center (DRC) at UNMC offers a dynamic and collaborative research environment. It houses state-of-the-art facilities and supports …"
— Divya Prakash G, 5★

Clinical Research Unit at Global Center for Health Security

3925 Dewey Ave, Omaha, NE 68198
(402) 836-9911

CCT Research at Midwest Regional Health Services

2727 S 144th St Ste 260 & Suite 280, Omaha, NE 68144
(402) 983-8348

Synexus - Omaha

★ 2.3
11020 Prairie Brook Rd, Omaha, NE 68144
(402) 205-7998
"Serious organization and communication issues. I question your ability to run a valid study."
— Sue, 1★

Eppley Institute For Research

985950 Nebraska, Omaha, NE 68198
(402) 559-4090

UNMC Munroe-Meyer Institute, Scott Campus

★ 3.6
6902 Pine St, Omaha, NE 68106
(402) 559-6418
"They treat their clients very well!"
— Victoria Christian, 5★

Clinical trials in Omaha: what's recruiting

The Omaha area currently has 593 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Omaha, the most active research areas are:

  • Cancer & Oncology17 studies
  • Heart & Vascular2 studies
  • Diabetes & Metabolism1 studies
  • Lungs & Breathing1 studies
  • Liver & Kidney1 studies

Every listing shows the study phase, the recruiting site and its distance from Omaha, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Omaha

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Omaha participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Are clinical trials in Omaha safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
What is the difference between a research center and a hospital study in Omaha?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Omaha?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Omaha.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Omaha typically complete one or two studies per year.

Paid clinical trials near Omaha

Other metros within reach

Lincoln, NE159 Topeka, KS111 Sioux Falls, SD259 Des Moines, IA220 Kansas City, KS1,043 Kansas City, MO1,031 Olathe, KS1,039 Overland Park, KS1,030

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Omaha Severe Chronic Pruritus in Omaha Heart Failure in Omaha Bladder Issues Due To Spinal Cord Injury in Omaha All conditions

More of NE

Lincoln159

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts